Evid Invest
Who owns BRVEWhat BRVE owns — n/a

Who owns Braveheart Bio, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of BRVE from SEC Form 13F filings across 64 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 64 institutions disclosed 73.4M shares of Braveheart Bio, Inc. worth $1.48B — about 141% of shares outstanding; the largest disclosed holder is FCPM III SERVICES B.V.. Source: SEC Form 13F filings, parsed by EvidInvest.

64

13F holders

$1.48B

value, 2026 filers

141%

of shares outstanding (73.4M sh)

64

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of BRVE's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1FCPM III SERVICES B.V.NEW21.8M$440.9M41.6%41.9%new
2ORBIMED ADVISORS LLCNEW12.2M$245.9M4.5%23.4%new
3a16z Capital Management, L.L.C.NEW10.2M$206.7M1.0%19.6%new
4FMR LLCNEW7.6M$153.2M0.0%14.6%new
5Frazier Life Sciences Management, L.P.NEW5.3M$106.4M2.6%10.1%new
6ENAVATE SCIENCES GP, LLCNEW3.7M$74.2M26.5%7.1%new
7Capital International InvestorsNEW1.3M$26.3M0.0%2.5%new
8Avoro Capital Advisors LLCNEW1.3M$25.4M0.3%2.4%new
9Capital Research Global InvestorsNEW1.0M$20.9M0.0%2%new
10BlackRock, Inc.NEW1.0M$20.3M0.0%1.9%new
11VANGUARD CAPITAL MANAGEMENT LLCNEW992,741$20.1M0.0%1.9%new
12EVENTIDE ASSET MANAGEMENT, LLCNEW910,000$18.4M0.3%1.7%new
13RA CAPITAL MANAGEMENT, L.P.NEW565,000$11.4M0.1%1.1%new
14Woodline Partners LPNEW502,718$10.2M0.0%1%new
15MASSACHUSETTS FINANCIAL SERVICES CO /MA/NEW465,251$9.4M0.0%0.9%new
16Nextech Invest Ltd.NEW416,700$8.4M0.4%0.8%new
17EcoR1 Capital, LLCNEW416,700$8.4M0.4%0.8%new
18Casdin Capital, LLCNEW400,000$8.1M0.4%0.8%new
19Pivotal bioVenture Partners Investment Advisor LLCNEW317,351$6.4M2.5%0.6%new
20T. Rowe Price Investment Management, Inc.NEW310,097$6.3M0.0%0.6%new
21GEODE CAPITAL MANAGEMENT, LLCNEW288,798$5.8M0.0%0.6%new
22FARALLON CAPITAL MANAGEMENT, L.L.C.NEW277,778$5.6M0.0%0.5%new
23UBS Group AGNEW229,072$4.6M0.0%0.4%new
24CHARLES SCHWAB INVESTMENT MANAGEMENT INCNEW146,453$3.0M0.0%0.3%new
25VANGUARD FIDUCIARY TRUST CONEW139,247$2.8M0.0%0.3%new

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.